PANENI, Maria Silvia
PANENI, Maria Silvia
Dipartimento di Ingegneria e Architettura
Settore ING-IND/24 - Principi di Ingegneria Chimica
"Fatty" nucleoside analogs as HCV NS5b inhibitors
2004-01-01 Pricl, Sabrina; Fermeglia, Maurizio; Ferrone, Marco; Coslanich, Alessandro; Paneni, Maria Silvia; Manfredini, S.; Angusti, A.; La Colla, P.; Mura, M.
3-Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: A novel class of potent tubulin inhibitors
2011-01-01 Carta, A.; Briguglio, I.; Piras, S.; Boatto, G.; la Colla, P.; Loddo, R.; Tolomeo, M.; Grimaudo, S.; Di Cristina, A.; Pipitone, M. R.; Laurini, Erik; Paneni, Maria Silvia; Posocco, Paola; Fermeglia, Maurizio; Pricl, Sabrina
A new mutation affecting the ATP pocket of kit receptor in patients with GIST showing acquired resistance to Imatinib: A coupled experimental and modeling investigation
2004-01-01 Pricl, Sabrina; Coslanich, A.; Fermeglia, Maurizio; Ferrone, Marco; Paneni, Maria Silvia; Tamborini, E.; Pilotti, S.; Pierotti, M. A.
A simple but effective three-dimensional chemical feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA-polymerase inhibitors
2005-01-01 DI SANTO, R.; Fermeglia, Maurizio; Ferrone, Marco; Paneni, Maria Silvia; Costi, R.; Artico, M.; Roux, A.; Gabriele, M.; Tardiff, K. D.; Siddiqui, A.; Pricl, Sabrina
A talk on the motor side. The free energy for mutating V186 and F244 to Leucine in beta-myosin and its ATP binding
2004-01-01 Paneni, Maria Silvia; Ferrone, Marco; Coslanich, A:; Fermeglia, Maurizio; Pricl, Sabrina; Miertus, S.; Frecer, V.; Carniel, E.; Mestroni, L.
Analogies in imatinib-resistant threonine-to-isoleucine mutation in bcr-abl, kit and pdgfra: a combined experimental/computational approach
2004-01-01 Pricl, Sabrina; Coslanich, Alessandro; Fermeglia, Maurizio; Ferro, M.; Ferrone, Marco; Paneni, Maria Silvia; Tamborini, E.; Negri, T.; Lagonigro, S.; Greco, A.; Gabanti, E.; Pierotti, M. A.; Pilotti, S.
Angels and demons of the guardian of the genome. A coupled modeling-biochemical study of p53 mutants in ovarian cancer.
2006-01-01 Pricl, Sabrina; Ferrone, Marco; Paneni, Maria Silvia; Cosoli, P.; Fermeglia, Maurizio; Perrone, F.; Da Riva, L.; Tamborini, E.; Suardi, S.; Pierotti, M. P.; Pilotti, S.
Antimicrobial and cytotoxic arylazoenamines. Part III: Antiviral activity of selected classes of arylazoenamines
2008-01-01 Michele, Tonelli; Vito, Boido; Caterina, Canu; Sparatore, A; Sparatore, F; Paneni, Maria Silvia; Fermeglia, Maurizio; Pricl, Sabrina; LA COLLA, P; Casula, L; Ibba, C; Collu, D; Loddo, R.
Antiviral and cytotoxic activities of aminoarylazo compoundsand aryltriazene derivatives
2009-01-01 Tonelli, M; Vazzana, I; Tasso, B; Boido, V; Sparatore, F; Fermeglia, Maurizio; Paneni, Maria Silvia; Posocco, Paola; Pricl, Sabrina; LA COLLA, P; Ibba, C; Secci, B; Collu, G; Loddo, R.
Can computational structural biology be of help in rationalizing clinical data? The Abl/imatinib paradigm
2005-01-01 Pricl, Sabrina; Tamborini, E.; Ferrone, Marco; Paneni, Maria Silvia; Fermeglia, Maurizio; Pierotti, M. A.; Pilotti, S.
Changes and challenges: GIST, mutated C-KIT and imatinib resistance
2005-01-01 Pricl, Sabrina; Ferrone, Marco; Paneni, Maria Silvia; Cosoli, P.; Fermeglia, Maurizio; Pierotti, M. A.; Pilotti, S.; Tamborini, E.
Computer simulation of polymer-organoclay nanocomposites for packaging applications: From binding energy to interlayer spacing predictions
2004-01-01 Pricl, Sabrina; Scocchi, Giulio; Fermeglia, Maurizio; Ferrone, Marco; Coslanich, A.; Paneni, Maria Silvia
Delivered to Perfection at Nanoscale. A Coupled Multiscale Simulation/Experimental Investigation of Protein Release from Nanochannel Delivery Systems
2006-01-01 Fermeglia, Maurizio; Ferrone, Marco; Cosoli, P.; Paneni, Maria Silvia; Cosentino, C.; Amato, F.; Cheng, M. M. C.; Walczak, R.; Pricl, Sabrina; Ferrari, M.
Design, synthesis and activity of hindered nucleoside analogs with anti-Flaviviridae activity, and their interaction with RdRp
2004-01-01 Pricl, Sabrina; Ferrone, Marco; Paneni, Maria Silvia; Angusti, A.; Manfredini, S.; La Colla, P.; Mura, M.
Design, synthesis and characterization of folate-cyclodextrin bioconjugate for active drug delivery: results from combined computational and experimental efforts
2004-01-01 Pricl, Sabrina; Fermeglia, Maurizio; Coslanich, Alessandro; Ferrone, Marco; Paneni, Maria Silvia; Caliceti, P.; Salmaso, S.; Semenzato, S.
Diblock copolymers for the automotive industry: the mesoscopic approach
2004-01-01 Coslanich, Alessandro; Fermeglia, Maurizio; Ferrone, Marco; Paneni, Maria Silvia; Pricl, Sabrina; Martinelli, L.; Sinesi, S.
Fighting cancer at the nanoscale: computational structural biology and the Bcr-Abl/Imatinib paradigm
2005-01-01 Ferrone, Marco; Paneni, Maria Silvia; Cosoli, P.; Fermeglia, Maurizio; Tamborini, E.; Pierotti, M. A.; Pilotti, S.; Pricl, Sabrina
Functional analysis and molecular modelling show a preserved wild type activity of p53 C238Y
2006-01-01 Ferrone, Marco; Perrone, F; Tamborini, E; Paneni, Maria Silvia; Fermeglia, Maurizio; Suardi, S; Pastore, E; Delia, D; PIEROTTI M., A; Pricl, Sabrina; Pilotti, S.
Genotype-phenotype correlations of myosin mutations: a molecular simulation study
2004-01-01 Paneni, Maria Silvia; Ferrone, Marco; Pricl, Sabrina; Carniel, E.; Miertus, S.; Frecer, V.; Mestroni, L.
Integrated process of design, synthesis and physicochemical characterization of nanovectors for active drug delivery: the cyclodextrin-folate-bioconjugate example
2003-01-01 Coslanich, A.; Fermeglia, Maurizio; Ferrone, Marco; Paneni, Maria Silvia; Pricl, Sabrina; Caliceti, P.; Carofiglio, T.; Fornasier, R.; Salmaso, S.; Semenzato, A.